Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (64.4%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (35.6%).
Net sales are distributed geographically as follows: Italy (14.3%), Europe (56.1%), America (20.4%), Asia and Oceania (6.7%) and Africa (2.5%).
- pharmaceutical and OTC products (64.4%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (35.6%).
Net sales are distributed geographically as follows: Italy (14.3%), Europe (56.1%), America (20.4%), Asia and Oceania (6.7%) and Africa (2.5%).
Source: Cofisem - Last Update: 2025-11-13
Key Executives
| Chief Executive Officer | |
| Chief Financial Officer | |
| Chief Human Resources Officer | |
| General Counsel | |
| Chief Communication Officer | |
| Corporate Development Director | |
| Head of Investor Relations | |
| Audit Director | |
| Chief Medical Officer | |
| Director Research & Development |
Source: Cofisem - Last Update: 2025-11-13
Key Figures
| Millenium | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Net sales | 2,341,559 | 2,082,331 | 1,853,307 | 1,580,074 | 1,448,867 |
| Income from ordinary activities | 2,341,559 | 2,082,331 | 1,853,307 | 1,580,074 | 1,448,867 |
| Operating income | 638,857 | 558,008 | 437,326 | 490,190 | 469,016 |
| Cost of financial indebtedness net | 78,975 | 72,516 | 31,306 | 16,661 | 16,449 |
| Equity-accounted companies contribution to income | |||||
| Net profit from discontinued activities | |||||
| Net income | 416,508 | 389,214 | 312,336 | 385,966 | 355,027 |
| Net income (Group share) | 416,508 | 389,214 | 312,336 | 385,966 | 354,984 |
| Fiscal year end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
Source: Cofisem - Last Update: 2025-11-13
Shareholder information
| Free float | |
| CVC Capital Partners Ltd. | |
| Treasury shares |
Source: Cofisem - Last Update: 2025-11-13
Address
Recordati
Via Matteo Civitali 1
IT-20148 Milano
Italy
Phone number: +39 (0)2 48 78 71
Fax: +39 (0)2 40 073 747
https://recordati.com/
Source: Cofisem - Last Update: 2025-11-13
Contact
Please contact MyQuestion.Italy@euronext.com for Company Profile support.